{"transactions":[{"id":730200,"issuer":{"id":4569,"kind":"organization","name":"Kardigan, Inc."},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-22T23:19:15.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":20706,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share is represented by a restricted stock unit (\"RSU\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. The RSUs vest in full on June 17, 2028, subject to the Reporting Person's continuous service as of the applicable vesting date."}],"balance_after":20706,"source":{"system":"sec-edgar","filing":"0001193125-26-277921","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1333482/000119312526277921/ownership.xml","form_type":"4"}},{"id":745897,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true}}],"security":"Class A Common Stock","published_at":"2026-06-08T23:25:23.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":8829,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/4th of the RSUs shall vest on each quarterly anniversary measured from May 21, 2026, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":37445,"source":{"system":"sec-edgar","filing":"0001610717-26-000193","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1333482/000161071726000193/form4.xml","form_type":"4"}},{"id":754858,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2026-06-02T20:51:17.000Z","date":"2026-05-29","kind":"exercise","planned":false,"acquired":false,"shares":2799,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vested in a single installment on May 29, 2026; there was no expiration date for the RSUs."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs vested in a single installment on May 29, 2026; there was no expiration date for the RSUs."}],"balance_after":0,"derivative":{"underlying":"Class A Ordinary Shares","underlying_shares":2799},"source":{"system":"sec-edgar","filing":"0001333482-26-000002","document":"form4-06022026_080611.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000133348226000002/form4-06022026_080611.xml","form_type":"4"}},{"id":754857,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2026-06-02T20:51:17.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":2026,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest in their entirety on the earlier of a) the anniversary of the date of the grant and b) the date of the Issuer's annual meeting of shareholders in the following year. The date of the grant is May 29, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest in their entirety on the earlier of a) the anniversary of the date of the grant and b) the date of the Issuer's annual meeting of shareholders in the following year. The date of the grant is May 29, 2026."}],"balance_after":2026,"derivative":{"underlying":"Class A Ordinary Shares","underlying_shares":2026},"source":{"system":"sec-edgar","filing":"0001333482-26-000002","document":"form4-06022026_080611.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000133348226000002/form4-06022026_080611.xml","form_type":"4"}},{"id":754856,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option","published_at":"2026-06-02T20:51:17.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":12158,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable in twelve substantially equal monthly installments following the date of the grant with the final installment vesting on the earlier of a) the anniversary of the date of the grant and b) the date of the Issuer's annual meeting of shareholders in the following year. The date of the grant is May 29, 2026."}],"balance_after":12158,"derivative":{"exercise_price":48.38,"expiration_date":"2036-05-28","underlying":"Class A Ordinary Shares","underlying_shares":12158},"source":{"system":"sec-edgar","filing":"0001333482-26-000002","document":"form4-06022026_080611.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000133348226000002/form4-06022026_080611.xml","form_type":"4"}},{"id":754855,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Share","published_at":"2026-06-02T20:51:17.000Z","date":"2026-05-29","kind":"exercise","planned":false,"acquired":true,"shares":2799,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."}],"balance_after":15345,"source":{"system":"sec-edgar","filing":"0001333482-26-000002","document":"form4-06022026_080611.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000133348226000002/form4-06022026_080611.xml","form_type":"4"}},{"id":815911,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2026-04-03T21:35:38.000Z","date":"2026-04-01","kind":"grant","planned":false,"acquired":true,"shares":10257,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock options were granted on April 1, 2026. The options vest and become exercisable in three substantially equal annual installments subject to the Reporting Person continuing in service through each such vesting date."}],"balance_after":10257,"derivative":{"exercise_price":88.12,"expiration_date":"2036-03-31","underlying":"Common Stock","underlying_shares":10257},"source":{"system":"sec-edgar","filing":"0001104659-26-039685","document":"tm2611099-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1333482/000110465926039685/tm2611099-2_4seq1.xml","form_type":"4"}},{"id":815910,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-04-03T21:35:38.000Z","date":"2026-04-01","kind":"grant","planned":false,"acquired":true,"shares":6808,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units will vest as to 33% of the total shares on each of April 1, 2027, April 1, 2028, April 1, 2029. The restricted stock units have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units will vest as to 33% of the total shares on each of April 1, 2027, April 1, 2028, April 1, 2029. The restricted stock units have no expiration date."}],"balance_after":6808,"derivative":{"underlying":"Common Stock","underlying_shares":6808},"source":{"system":"sec-edgar","filing":"0001104659-26-039685","document":"tm2611099-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1333482/000110465926039685/tm2611099-2_4seq1.xml","form_type":"4"}},{"id":831139,"issuer":{"id":56619,"kind":"organization","name":"EXACT SCIENCES CORP","symbol":"EXAS"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-23T09:18:33.000Z","date":"2026-03-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":9656,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the Effective Time, each share of Common Stock subject to vesting, repurchase or other lapse restriction and that was granted under an Issuer stock plan and outstanding as of immediately prior to the Effective Time was deemed to be fully vested and cancelled and converted into the right to receive the Merger Consideration, less any applicable tax withholding."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-118745","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1124140/000119312526118745/ownership.xml","form_type":"4"}},{"id":831138,"issuer":{"id":56619,"kind":"organization","name":"EXACT SCIENCES CORP","symbol":"EXAS"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-23T09:18:33.000Z","date":"2026-03-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":6725,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 23, 2026, pursuant to the terms of that certain Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of November 19, 2025, by and among Exact Sciences Corporation, a Delaware corporation (the \"Issuer\"), Abbott Laboratories, an Illinois corporation (\"Parent\"), and Badger Merger Sub I, Inc., a Delaware corporation and a direct, wholly owned subsidiary of Parent (\"Merger Sub\"), Merger Sub merged with and into the Issuer (the \"Merger\"), with the Issuer surviving the Merger as a direct, wholly owned subsidiary of Parent. At the effective time of the Merger (the \"Effective Time\"), on the terms and subject to the conditions set forth in the Merger Agreement, each share of the Issuer's common stock, par value $0.01 per share (\"Common Stock\"), issued and outstanding immediately prior to the Effective Time, with certain exceptions, was converted into the right to receive $105.00 in cash, without interest (the \"Merger Consideration\")."}],"balance_after":9656,"source":{"system":"sec-edgar","filing":"0001193125-26-118745","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124140/000119312526118745/ownership.xml","form_type":"4"}},{"id":1077647,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option","published_at":"2025-08-01T20:36:07.000Z","date":"2025-07-30","kind":"exercise","planned":false,"acquired":false,"shares":18760,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":15.47,"expiration_date":"2029-05-28","underlying":"Class A Ordinary Shares","underlying_shares":18760},"source":{"system":"sec-edgar","filing":"0001415889-25-020866","document":"form4-08012025_080803.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925020866/form4-08012025_080803.xml","form_type":"4"}},{"id":1077646,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option","published_at":"2025-08-01T20:36:07.000Z","date":"2025-07-30","kind":"exercise","planned":false,"acquired":false,"shares":45748,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":10.36,"expiration_date":"2028-02-29","underlying":"Class A Ordinary Shares","underlying_shares":45748},"source":{"system":"sec-edgar","filing":"0001415889-25-020866","document":"form4-08012025_080803.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925020866/form4-08012025_080803.xml","form_type":"4"}},{"id":1077645,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Share","published_at":"2025-08-01T20:36:07.000Z","date":"2025-07-30","kind":"exercise","planned":false,"acquired":false,"shares":64508,"price":29.9,"value":1928789.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging between $29.66 and $30.07. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price."}],"balance_after":12546,"source":{"system":"sec-edgar","filing":"0001415889-25-020866","document":"form4-08012025_080803.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925020866/form4-08012025_080803.xml","form_type":"4"}},{"id":1077644,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Share","published_at":"2025-08-01T20:36:07.000Z","date":"2025-07-30","kind":"exercise","planned":false,"acquired":true,"shares":18760,"price":15.47,"value":290217.2,"ownership":{"direct":true},"balance_after":77054,"source":{"system":"sec-edgar","filing":"0001415889-25-020866","document":"form4-08012025_080803.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925020866/form4-08012025_080803.xml","form_type":"4"}},{"id":1077643,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Share","published_at":"2025-08-01T20:36:07.000Z","date":"2025-07-30","kind":"exercise","planned":false,"acquired":true,"shares":45748,"price":10.36,"value":473949.28,"ownership":{"direct":true},"balance_after":58294,"source":{"system":"sec-edgar","filing":"0001415889-25-020866","document":"form4-08012025_080803.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925020866/form4-08012025_080803.xml","form_type":"4"}},{"id":1110218,"issuer":{"id":56619,"kind":"organization","name":"EXACT SCIENCES CORP","symbol":"EXAS"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-16T17:30:15.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":9994,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares of restricted stock were issued pursuant to the Company's non-employee director compensation policy."}],"balance_after":16381,"source":{"system":"sec-edgar","filing":"0000950170-25-086888","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124140/000095017025086888/ownership.xml","form_type":"4"}},{"id":1121008,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true}}],"security":"Class A Common Stock","published_at":"2025-06-05T21:21:37.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":15357,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/4th of the RSUs shall vest on each quarterly anniversary measured from May 21, 2025, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":28616,"source":{"system":"sec-edgar","filing":"0001610717-25-000169","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1333482/000161071725000169/form4.xml","form_type":"4"}},{"id":1121399,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2025-06-05T20:55:57.000Z","date":"2025-06-05","kind":"exercise","planned":false,"acquired":false,"shares":3173,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vested in a single installment on June 5, 2025; there was no expiration date for the RSUs."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs vested in a single installment on June 5, 2025; there was no expiration date for the RSUs."}],"balance_after":0,"derivative":{"underlying":"Class A Ordinary Shares","underlying_shares":3173},"source":{"system":"sec-edgar","filing":"0001415889-25-015788","document":"form4-06052025_080613.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925015788/form4-06052025_080613.xml","form_type":"4"}},{"id":1121398,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2025-06-05T20:55:57.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":2799,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest in their entirety on the earlier of a) the anniversary of the date of the grant and b) the date of the Issuer's annual meeting of shareholders in the following year. The date of the grant is June 3, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest in their entirety on the earlier of a) the anniversary of the date of the grant and b) the date of the Issuer's annual meeting of shareholders in the following year. The date of the grant is June 3, 2025."}],"balance_after":2799,"derivative":{"underlying":"Class A Ordinary Shares","underlying_shares":2799},"source":{"system":"sec-edgar","filing":"0001415889-25-015788","document":"form4-06052025_080613.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925015788/form4-06052025_080613.xml","form_type":"4"}},{"id":1121397,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option","published_at":"2025-06-05T20:55:57.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":16798,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable in twelve substantially equal monthly installments following the date of the grant with the final installment vesting on the earlier of a) the anniversary of the date of the grant and b) the date of the Issuer's annual meeting of shareholders in the following year. The date of the grant is June 3, 2025."}],"balance_after":16798,"derivative":{"exercise_price":29.11,"expiration_date":"2035-06-02","underlying":"Class A Ordinary Shares","underlying_shares":16798},"source":{"system":"sec-edgar","filing":"0001415889-25-015788","document":"form4-06052025_080613.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925015788/form4-06052025_080613.xml","form_type":"4"}},{"id":1121396,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Share","published_at":"2025-06-05T20:55:57.000Z","date":"2025-06-05","kind":"exercise","planned":false,"acquired":true,"shares":3173,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."}],"balance_after":12546,"source":{"system":"sec-edgar","filing":"0001415889-25-015788","document":"form4-06052025_080613.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925015788/form4-06052025_080613.xml","form_type":"4"}},{"id":1311456,"issuer":{"id":56619,"kind":"organization","name":"EXACT SCIENCES CORP","symbol":"EXAS"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-06T16:12:10.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":6387,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These shares of restricted stock were issued pursuant to the Company's non-employee director compensation policy and vest in three equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":6387,"source":{"system":"sec-edgar","filing":"0000950170-25-002084","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124140/000095017025002084/ownership.xml","form_type":"4"}},{"id":1480321,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true}}],"security":"Class A Common Stock","published_at":"2024-06-13T20:24:25.000Z","date":"2024-06-11","kind":"grant","planned":false,"acquired":true,"shares":8649,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/4th of the RSUs shall vest on each quarterly anniversary measured from May 21, 2024, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":13259,"source":{"system":"sec-edgar","filing":"0001610717-24-000328","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1333482/000161071724000328/form4.xml","form_type":"4"}},{"id":1486888,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2024-06-07T20:36:22.000Z","date":"2024-06-06","kind":"exercise","planned":false,"acquired":false,"shares":4373,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vested in a single installment on June 6, 2024; there was no expiration date for the RSUs."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs vested in a single installment on June 6, 2024; there was no expiration date for the RSUs."}],"balance_after":0,"derivative":{"underlying":"Class A Common Shares","underlying_shares":4373},"source":{"system":"sec-edgar","filing":"0001415889-24-015997","document":"form4-06072024_080618.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588924015997/form4-06072024_080618.xml","form_type":"4"}},{"id":1486887,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2024-06-07T20:36:22.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":3173,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest in their entirety on the first anniversary date of the grant, June 5, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest in their entirety on the first anniversary date of the grant, June 5, 2024."}],"balance_after":3173,"derivative":{"underlying":"Class A Common Shares","underlying_shares":3173},"source":{"system":"sec-edgar","filing":"0001415889-24-015997","document":"form4-06072024_080618.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588924015997/form4-06072024_080618.xml","form_type":"4"}},{"id":1486886,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option","published_at":"2024-06-07T20:36:22.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":19040,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable in twelve substantially equal monthly installments following the date of the grant. The date of the grant is June 5, 2024."}],"balance_after":19040,"derivative":{"exercise_price":19.71,"expiration_date":"2034-06-04","underlying":"Class A Common Shares","underlying_shares":19040},"source":{"system":"sec-edgar","filing":"0001415889-24-015997","document":"form4-06072024_080618.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588924015997/form4-06072024_080618.xml","form_type":"4"}},{"id":1486885,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Share","published_at":"2024-06-07T20:36:22.000Z","date":"2024-06-06","kind":"exercise","planned":false,"acquired":true,"shares":4373,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer."}],"balance_after":9373,"source":{"system":"sec-edgar","filing":"0001415889-24-015997","document":"form4-06072024_080618.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588924015997/form4-06072024_080618.xml","form_type":"4"}},{"id":1839765,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2023-07-03T20:15:12.000Z","date":"2023-06-29","kind":"exercise","planned":false,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested in a single installment on June 29, 2023; there was no expiration date for the RSUs."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vested in a single installment on June 29, 2023; there was no expiration date for the RSUs."}],"balance_after":0,"derivative":{"underlying":"Class A Common Shares","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001415889-23-010561","document":"form4-07032023_040706.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588923010561/form4-07032023_040706.xml","form_type":"4"}},{"id":1839764,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Share","published_at":"2023-07-03T20:15:12.000Z","date":"2023-06-29","kind":"exercise","planned":false,"acquired":true,"shares":5000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001415889-23-010561","document":"form4-07032023_040706.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588923010561/form4-07032023_040706.xml","form_type":"4"}},{"id":1851685,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2023-06-16T21:41:33.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":4661,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/12th of the total number of shares subject to the option vest on each monthly anniversary measured from June 14, 2023, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":4661,"derivative":{"exercise_price":57.62,"expiration_date":"2033-06-14","underlying":"Class A Common Stock","underlying_shares":4661},"source":{"system":"sec-edgar","filing":"0001610717-23-000174","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1333482/000161071723000174/form4.xml","form_type":"4"}},{"id":1851684,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true}}],"security":"Class A Common Stock","published_at":"2023-06-16T21:41:33.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":1865,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/4th of the RSUs shall vest on each quarterly anniversary measured from May 21, 2023, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":4610,"source":{"system":"sec-edgar","filing":"0001610717-23-000174","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1333482/000161071723000174/form4.xml","form_type":"4"}},{"id":1858491,"issuer":{"id":87664,"kind":"organization","name":"Talis Biomedical Corp","symbol":"TLIS"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2023-06-12T21:26:16.000Z","date":"2023-06-09","kind":"grant","planned":false,"acquired":true,"shares":95000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the shares subject to the option shall vest monthly over one year from the vesting commencement date."}],"balance_after":95000,"derivative":{"exercise_price":0.5,"expiration_date":"2033-06-09","underlying":"Common Stock","underlying_shares":95000},"source":{"system":"sec-edgar","filing":"0001209191-23-036398","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1333482/000120919123036398/doc4.xml","form_type":"4"}},{"id":1862471,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2023-06-08T20:22:38.000Z","date":"2023-06-06","kind":"grant","planned":false,"acquired":true,"shares":4373,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest in their entirety on the first anniversary of the date of the grant, June 6, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest in their entirety on the first anniversary of the date of the grant, June 6, 2023."}],"balance_after":4373,"derivative":{"underlying":"Class A Common Shares","underlying_shares":4373},"source":{"system":"sec-edgar","filing":"0001415889-23-009429","document":"form4-06082023_080635.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588923009429/form4-06082023_080635.xml","form_type":"4"}},{"id":1862470,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option","published_at":"2023-06-08T20:22:38.000Z","date":"2023-06-06","kind":"grant","planned":false,"acquired":true,"shares":26236,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in twelve substantially equal monthly installments following the date of the grant. The date of the grant is June 6, 2023."}],"balance_after":26236,"derivative":{"exercise_price":15.19,"expiration_date":"2033-06-05","underlying":"Class A Common Shares","underlying_shares":26236},"source":{"system":"sec-edgar","filing":"0001415889-23-009429","document":"form4-06082023_080635.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588923009429/form4-06082023_080635.xml","form_type":"4"}},{"id":2218733,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2022-06-30T20:18:55.000Z","date":"2022-06-29","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest in their entirety on the first anniversary of the date of grant, June 29, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest in their entirety on the first anniversary of the date of grant, June 29, 2022."}],"balance_after":5000,"derivative":{"underlying":"Class A Common Shares","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001415889-22-007104","document":"form4-06302022_010644.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588922007104/form4-06302022_010644.xml","form_type":"4"}},{"id":2218732,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option","published_at":"2022-06-30T20:18:55.000Z","date":"2022-06-29","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in twelve substantially equal monthly installments following the date of grant. The date of grant is June 29, 2022."}],"balance_after":30000,"derivative":{"exercise_price":9.88,"expiration_date":"2032-06-28","underlying":"Class A Common Shares","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001415889-22-007104","document":"form4-06302022_010644.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588922007104/form4-06302022_010644.xml","form_type":"4"}},{"id":2227148,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-17T21:24:47.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":5300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option, granted pursuant to the Issuer's 2019 Omnibus Incentive Plan, vests as to one-twelfth of the shares on July 15, 2022 and each month thereafter, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":5300,"derivative":{"exercise_price":39.62,"expiration_date":"2032-06-15","underlying":"Class A Common Stock","underlying_shares":5300},"source":{"system":"sec-edgar","filing":"0001567619-22-013122","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1333482/000156761922013122/doc1.xml","form_type":"4"}},{"id":2227147,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2022-06-17T21:24:47.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":2120,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities are restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Class A Common Stock. One-fourth of the RSUs, granted pursuant to the Issuer's 2019 Omnibus Incentive Plan, shall vest on August 21, 2022 and on each three-month anniversary thereafter, subject to the Reporting Person\ncontinuing as a service provider through each such date."}],"balance_after":2745,"source":{"system":"sec-edgar","filing":"0001567619-22-013122","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1333482/000156761922013122/doc1.xml","form_type":"4"}},{"id":2233801,"issuer":{"id":87664,"kind":"organization","name":"Talis Biomedical Corp","symbol":"TLIS"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-13T21:39:48.000Z","date":"2022-06-10","kind":"grant","acquired":true,"shares":95000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the shares subject to the option shall vest monthly over one year from the vesting commencement date."}],"balance_after":95000,"derivative":{"exercise_price":1,"expiration_date":"2032-06-09","underlying":"Common Stock","underlying_shares":95000},"source":{"system":"sec-edgar","filing":"0001209191-22-036423","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1333482/000120919122036423/doc4.xml","form_type":"4"}},{"id":2584861,"issuer":{"id":87664,"kind":"organization","name":"Talis Biomedical Corp","symbol":"TLIS"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO"}}],"security":"Stock Option (right to buy)","published_at":"2021-09-01T01:01:46.000Z","date":"2021-08-30","kind":"grant","acquired":true,"shares":550000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the shares subject to the option shall vest monthly over one year from the vesting commencement date."}],"balance_after":550000,"derivative":{"exercise_price":9.06,"expiration_date":"2031-08-29","underlying":"Common Stock","underlying_shares":550000},"source":{"system":"sec-edgar","filing":"0001209191-21-054181","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1333482/000120919121054181/doc4.xml","form_type":"4"}},{"id":2650183,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option","published_at":"2021-06-30T20:22:02.000Z","date":"2021-06-29","kind":"grant","acquired":true,"shares":33237,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in twelve substantially equal monthly installments following the date of grant. The date of grant is June 29, 2021."}],"balance_after":33237,"derivative":{"exercise_price":14.33,"expiration_date":"2031-06-28","underlying":"Class A Common Shares","underlying_shares":33237},"source":{"system":"sec-edgar","filing":"0001179110-21-007185","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000117911021007185/edgar.xml","form_type":"4"}},{"id":2667875,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-15T21:51:43.000Z","date":"2021-06-11","kind":"grant","acquired":true,"shares":1563,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option, granted pursuant to the Issuer's 2019 Omnibus Incentive Plan, vests as to one-twelfth of the shares on July 11, 2021 and each month thereafter, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":1563,"derivative":{"exercise_price":193.51,"expiration_date":"2031-06-11","underlying":"Class A Common Stock","underlying_shares":1563},"source":{"system":"sec-edgar","filing":"0001209191-21-040690","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1333482/000120919121040690/doc4.xml","form_type":"4"}},{"id":2667874,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-06-15T21:51:43.000Z","date":"2021-06-11","kind":"grant","acquired":true,"shares":625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities are restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Class A Common Stock. One-fourth of the RSUs, granted pursuant to the Issuer's 2019 Omnibus Incentive Plan, shall vest on August 21, 2021 and on each three-month anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":625,"source":{"system":"sec-edgar","filing":"0001209191-21-040690","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1333482/000120919121040690/doc4.xml","form_type":"4"}},{"id":2845739,"issuer":{"id":87664,"kind":"organization","name":"Talis Biomedical Corp","symbol":"TLIS"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series F-1 Preferred Stock","published_at":"2021-02-19T23:21:13.000Z","date":"2021-02-17","kind":"exercise","acquired":false,"shares":128655,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By MSL FBO Kimberly J. Popovits Patrick J. Popovits TTEE U/A/D 05- 17-2010 FBO Popovits 2010 Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each share of Series F-1 Preferred Stock automatically converts on a 1-for-1.43 basis into Common Stock at any time at the holder's election and has no expiration date. At the closing of the Issuer's initial public offering, each share of Series F-1 Preferred stock converted into shares of Common Stock, for no additional consideration, at a rate of one share of Common Stock for each 1.43 shares of Series F-1 Preferred Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each share of Series F-1 Preferred Stock automatically converts on a 1-for-1.43 basis into Common Stock at any time at the holder's election and has no expiration date. At the closing of the Issuer's initial public offering, each share of Series F-1 Preferred stock converted into shares of Common Stock, for no additional consideration, at a rate of one share of Common Stock for each 1.43 shares of Series F-1 Preferred Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each share of Series F-1 Preferred Stock automatically converts on a 1-for-1.43 basis into Common Stock at any time at the holder's election and has no expiration date. At the closing of the Issuer's initial public offering, each share of Series F-1 Preferred stock converted into shares of Common Stock, for no additional consideration, at a rate of one share of Common Stock for each 1.43 shares of Series F-1 Preferred Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Ms. Popovits and her spouse are trustees of the MSL FBO Kimberly J. Popovits Patrick J. Popovits TTEE U/A/D 05-17-2010 FBO Popovits 2010\nTrust and share voting and dispositive power."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":89968},"source":{"system":"sec-edgar","filing":"0001209191-21-012522","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1333482/000120919121012522/doc4.xml","form_type":"4"}},{"id":2845738,"issuer":{"id":87664,"kind":"organization","name":"Talis Biomedical Corp","symbol":"TLIS"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series E-1 Preferred Stock","published_at":"2021-02-19T23:21:13.000Z","date":"2021-02-17","kind":"exercise","acquired":false,"shares":131642,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By MSL FBO Kimberly J. Popovits Patrick J. Popovits TTEE U/A/D 05- 17-2010 FBO Popovits 2010 Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each share of Series E-1 Preferred Stock automatically converts on a 1-for-1.43 basis into Common Stock at any time at the holder's election and has no expiration date. At the closing of the Issuer's initial public offering, each share of Series E-1 Preferred stock converted into shares of Common Stock, for no additional consideration, at a rate of one share of Common Stock for each 1.43 shares of Series E-1 Preferred Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each share of Series E-1 Preferred Stock automatically converts on a 1-for-1.43 basis into Common Stock at any time at the holder's election and has no expiration date. At the closing of the Issuer's initial public offering, each share of Series E-1 Preferred stock converted into shares of Common Stock, for no additional consideration, at a rate of one share of Common Stock for each 1.43 shares of Series E-1 Preferred Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of Series E-1 Preferred Stock automatically converts on a 1-for-1.43 basis into Common Stock at any time at the holder's election and has no expiration date. At the closing of the Issuer's initial public offering, each share of Series E-1 Preferred stock converted into shares of Common Stock, for no additional consideration, at a rate of one share of Common Stock for each 1.43 shares of Series E-1 Preferred Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Ms. Popovits and her spouse are trustees of the MSL FBO Kimberly J. Popovits Patrick J. Popovits TTEE U/A/D 05-17-2010 FBO Popovits 2010\nTrust and share voting and dispositive power."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":92057},"source":{"system":"sec-edgar","filing":"0001209191-21-012522","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1333482/000120919121012522/doc4.xml","form_type":"4"}},{"id":2845737,"issuer":{"id":87664,"kind":"organization","name":"Talis Biomedical Corp","symbol":"TLIS"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series E-1 Preferred Stock","published_at":"2021-02-19T23:21:13.000Z","date":"2021-02-17","kind":"exercise","acquired":false,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each share of Series E-1 Preferred Stock automatically converts on a 1-for-1.43 basis into Common Stock at any time at the holder's election and has no expiration date. At the closing of the Issuer's initial public offering, each share of Series E-1 Preferred stock converted into shares of Common Stock, for no additional consideration, at a rate of one share of Common Stock for each 1.43 shares of Series E-1 Preferred Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each share of Series E-1 Preferred Stock automatically converts on a 1-for-1.43 basis into Common Stock at any time at the holder's election and has no expiration date. At the closing of the Issuer's initial public offering, each share of Series E-1 Preferred stock converted into shares of Common Stock, for no additional consideration, at a rate of one share of Common Stock for each 1.43 shares of Series E-1 Preferred Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of Series E-1 Preferred Stock automatically converts on a 1-for-1.43 basis into Common Stock at any time at the holder's election and has no expiration date. At the closing of the Issuer's initial public offering, each share of Series E-1 Preferred stock converted into shares of Common Stock, for no additional consideration, at a rate of one share of Common Stock for each 1.43 shares of Series E-1 Preferred Stock."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":209790},"source":{"system":"sec-edgar","filing":"0001209191-21-012522","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1333482/000120919121012522/doc4.xml","form_type":"4"}},{"id":2845736,"issuer":{"id":87664,"kind":"organization","name":"Talis Biomedical Corp","symbol":"TLIS"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series C-1 Preferred Stock","published_at":"2021-02-19T23:21:13.000Z","date":"2021-02-17","kind":"exercise","acquired":false,"shares":31519,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series C-1 Preferred Stock automatically converts on a 1-for-1.43 basis into Common Stock at any time at the holder's election and has no expiration date. At the closing of the Issuer's initial public offering, each share of Series C-1 Preferred stock converted into shares of Common Stock, for no additional consideration, at a rate of one share of Common Stock for each 1.43 shares of Series C-1 Preferred Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series C-1 Preferred Stock automatically converts on a 1-for-1.43 basis into Common Stock at any time at the holder's election and has no expiration date. At the closing of the Issuer's initial public offering, each share of Series C-1 Preferred stock converted into shares of Common Stock, for no additional consideration, at a rate of one share of Common Stock for each 1.43 shares of Series C-1 Preferred Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series C-1 Preferred Stock automatically converts on a 1-for-1.43 basis into Common Stock at any time at the holder's election and has no expiration date. At the closing of the Issuer's initial public offering, each share of Series C-1 Preferred stock converted into shares of Common Stock, for no additional consideration, at a rate of one share of Common Stock for each 1.43 shares of Series C-1 Preferred Stock."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":22041},"source":{"system":"sec-edgar","filing":"0001209191-21-012522","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1333482/000120919121012522/doc4.xml","form_type":"4"}},{"id":2845735,"issuer":{"id":87664,"kind":"organization","name":"Talis Biomedical Corp","symbol":"TLIS"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-19T23:21:13.000Z","date":"2021-02-17","kind":"exercise","acquired":true,"shares":89968,"ownership":{"direct":false,"nature":"By MSL FBO Kimberly J. Popovits Patrick J. Popovits TTEE U/A/D 05- 17-2010 FBO Popovits 2010 Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each share of Series F-1 Preferred Stock automatically converts on a 1-for-1.43 basis into Common Stock at any time at the holder's election and has no expiration date. At the closing of the Issuer's initial public offering, each share of Series F-1 Preferred stock converted into shares of Common Stock, for no additional consideration, at a rate of one share of Common Stock for each 1.43 shares of Series F-1 Preferred Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Ms. Popovits and her spouse are trustees of the MSL FBO Kimberly J. Popovits Patrick J. Popovits TTEE U/A/D 05-17-2010 FBO Popovits 2010\nTrust and share voting and dispositive power."}],"balance_after":182025,"source":{"system":"sec-edgar","filing":"0001209191-21-012522","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1333482/000120919121012522/doc4.xml","form_type":"4"}},{"id":2845734,"issuer":{"id":87664,"kind":"organization","name":"Talis Biomedical Corp","symbol":"TLIS"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-19T23:21:13.000Z","date":"2021-02-17","kind":"exercise","acquired":true,"shares":92057,"ownership":{"direct":false,"nature":"By MSL FBO Kimberly J. Popovits Patrick J. Popovits TTEE U/A/D 05- 17-2010 FBO Popovits 2010 Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of Series E-1 Preferred Stock automatically converts on a 1-for-1.43 basis into Common Stock at any time at the holder's election and has no expiration date. At the closing of the Issuer's initial public offering, each share of Series E-1 Preferred stock converted into shares of Common Stock, for no additional consideration, at a rate of one share of Common Stock for each 1.43 shares of Series E-1 Preferred Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Ms. Popovits and her spouse are trustees of the MSL FBO Kimberly J. Popovits Patrick J. Popovits TTEE U/A/D 05-17-2010 FBO Popovits 2010\nTrust and share voting and dispositive power."}],"balance_after":92057,"source":{"system":"sec-edgar","filing":"0001209191-21-012522","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1333482/000120919121012522/doc4.xml","form_type":"4"}},{"id":2845733,"issuer":{"id":87664,"kind":"organization","name":"Talis Biomedical Corp","symbol":"TLIS"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-19T23:21:13.000Z","date":"2021-02-17","kind":"purchase","acquired":true,"shares":5300,"price":16,"value":84800.0,"ownership":{"direct":false,"nature":"By spouse"},"balance_after":215090,"source":{"system":"sec-edgar","filing":"0001209191-21-012522","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1333482/000120919121012522/doc4.xml","form_type":"4"}},{"id":2845732,"issuer":{"id":87664,"kind":"organization","name":"Talis Biomedical Corp","symbol":"TLIS"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-19T23:21:13.000Z","date":"2021-02-17","kind":"exercise","acquired":true,"shares":209790,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of Series E-1 Preferred Stock automatically converts on a 1-for-1.43 basis into Common Stock at any time at the holder's election and has no expiration date. At the closing of the Issuer's initial public offering, each share of Series E-1 Preferred stock converted into shares of Common Stock, for no additional consideration, at a rate of one share of Common Stock for each 1.43 shares of Series E-1 Preferred Stock."}],"balance_after":209790,"source":{"system":"sec-edgar","filing":"0001209191-21-012522","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1333482/000120919121012522/doc4.xml","form_type":"4"}},{"id":2845731,"issuer":{"id":87664,"kind":"organization","name":"Talis Biomedical Corp","symbol":"TLIS"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-19T23:21:13.000Z","date":"2021-02-17","kind":"exercise","acquired":true,"shares":22041,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series C-1 Preferred Stock automatically converts on a 1-for-1.43 basis into Common Stock at any time at the holder's election and has no expiration date. At the closing of the Issuer's initial public offering, each share of Series C-1 Preferred stock converted into shares of Common Stock, for no additional consideration, at a rate of one share of Common Stock for each 1.43 shares of Series C-1 Preferred Stock."}],"balance_after":25776,"source":{"system":"sec-edgar","filing":"0001209191-21-012522","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1333482/000120919121012522/doc4.xml","form_type":"4"}},{"id":2972856,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2020-11-20T01:16:28.000Z","date":"2020-11-17","kind":"disposition_to_issuer","acquired":false,"shares":3000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each Issuer option that was outstanding (whether vested or unvested) immediately prior to the Effective Time and then exercisable for a per share exercise price less than the Offer Price that would be payable in respect of the Shares underlying such Issuer option (was cancelled and automatically converted into solely the right to receive, for each Share underlying such Issuer option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of (i) the Offer Price over (ii) the per share exercise price of such Issuer option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each Issuer option that was outstanding (whether vested or unvested) immediately prior to the Effective Time and then exercisable for a per share exercise price less than the Offer Price that would be payable in respect of the Shares underlying such Issuer option (was cancelled and automatically converted into solely the right to receive, for each Share underlying such Issuer option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of (i) the Offer Price over (ii) the per share exercise price of such Issuer option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each Issuer option that was outstanding (whether vested or unvested) immediately prior to the Effective Time and then exercisable for a per share exercise price less than the Offer Price that would be payable in respect of the Shares underlying such Issuer option (was cancelled and automatically converted into solely the right to receive, for each Share underlying such Issuer option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of (i) the Offer Price over (ii) the per share exercise price of such Issuer option."}],"balance_after":0,"derivative":{"exercise_price":100.27,"underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0000899243-20-031749","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1333482/000089924320031749/doc4.xml","form_type":"4"}},{"id":2972855,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2020-11-20T01:16:28.000Z","date":"2020-11-17","kind":"disposition_to_issuer","acquired":false,"shares":6600,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each Issuer option that was outstanding (whether vested or unvested) immediately prior to the Effective Time and then exercisable for a per share exercise price less than the Offer Price that would be payable in respect of the Shares underlying such Issuer option (was cancelled and automatically converted into solely the right to receive, for each Share underlying such Issuer option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of (i) the Offer Price over (ii) the per share exercise price of such Issuer option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each Issuer option that was outstanding (whether vested or unvested) immediately prior to the Effective Time and then exercisable for a per share exercise price less than the Offer Price that would be payable in respect of the Shares underlying such Issuer option (was cancelled and automatically converted into solely the right to receive, for each Share underlying such Issuer option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of (i) the Offer Price over (ii) the per share exercise price of such Issuer option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each Issuer option that was outstanding (whether vested or unvested) immediately prior to the Effective Time and then exercisable for a per share exercise price less than the Offer Price that would be payable in respect of the Shares underlying such Issuer option (was cancelled and automatically converted into solely the right to receive, for each Share underlying such Issuer option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of (i) the Offer Price over (ii) the per share exercise price of such Issuer option."}],"balance_after":0,"derivative":{"exercise_price":47.77,"underlying":"Common Stock","underlying_shares":6600},"source":{"system":"sec-edgar","filing":"0000899243-20-031749","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1333482/000089924320031749/doc4.xml","form_type":"4"}},{"id":2972854,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2020-11-20T01:16:28.000Z","date":"2020-11-17","kind":"disposition_to_issuer","acquired":false,"shares":11000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each Issuer option that was outstanding (whether vested or unvested) immediately prior to the Effective Time and then exercisable for a per share exercise price less than the Offer Price that would be payable in respect of the Shares underlying such Issuer option (was cancelled and automatically converted into solely the right to receive, for each Share underlying such Issuer option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of (i) the Offer Price over (ii) the per share exercise price of such Issuer option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each Issuer option that was outstanding (whether vested or unvested) immediately prior to the Effective Time and then exercisable for a per share exercise price less than the Offer Price that would be payable in respect of the Shares underlying such Issuer option (was cancelled and automatically converted into solely the right to receive, for each Share underlying such Issuer option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of (i) the Offer Price over (ii) the per share exercise price of such Issuer option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each Issuer option that was outstanding (whether vested or unvested) immediately prior to the Effective Time and then exercisable for a per share exercise price less than the Offer Price that would be payable in respect of the Shares underlying such Issuer option (was cancelled and automatically converted into solely the right to receive, for each Share underlying such Issuer option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of (i) the Offer Price over (ii) the per share exercise price of such Issuer option."}],"balance_after":0,"derivative":{"exercise_price":48.85,"underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0000899243-20-031749","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1333482/000089924320031749/doc4.xml","form_type":"4"}},{"id":2972853,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2020-11-20T01:16:28.000Z","date":"2020-11-17","kind":"disposition_to_issuer","acquired":false,"shares":11000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each Issuer option that was outstanding (whether vested or unvested) immediately prior to the Effective Time and then exercisable for a per share exercise price less than the Offer Price that would be payable in respect of the Shares underlying such Issuer option (was cancelled and automatically converted into solely the right to receive, for each Share underlying such Issuer option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of (i) the Offer Price over (ii) the per share exercise price of such Issuer option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each Issuer option that was outstanding (whether vested or unvested) immediately prior to the Effective Time and then exercisable for a per share exercise price less than the Offer Price that would be payable in respect of the Shares underlying such Issuer option (was cancelled and automatically converted into solely the right to receive, for each Share underlying such Issuer option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of (i) the Offer Price over (ii) the per share exercise price of such Issuer option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each Issuer option that was outstanding (whether vested or unvested) immediately prior to the Effective Time and then exercisable for a per share exercise price less than the Offer Price that would be payable in respect of the Shares underlying such Issuer option (was cancelled and automatically converted into solely the right to receive, for each Share underlying such Issuer option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of (i) the Offer Price over (ii) the per share exercise price of such Issuer option."}],"balance_after":0,"derivative":{"exercise_price":14,"underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0000899243-20-031749","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1333482/000089924320031749/doc4.xml","form_type":"4"}},{"id":2972852,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2020-11-20T01:16:28.000Z","date":"2020-11-17","kind":"disposition_to_issuer","acquired":false,"shares":22000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each Issuer option that was outstanding (whether vested or unvested) immediately prior to the Effective Time and then exercisable for a per share exercise price less than the Offer Price that would be payable in respect of the Shares underlying such Issuer option (was cancelled and automatically converted into solely the right to receive, for each Share underlying such Issuer option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of (i) the Offer Price over (ii) the per share exercise price of such Issuer option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each Issuer option that was outstanding (whether vested or unvested) immediately prior to the Effective Time and then exercisable for a per share exercise price less than the Offer Price that would be payable in respect of the Shares underlying such Issuer option (was cancelled and automatically converted into solely the right to receive, for each Share underlying such Issuer option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of (i) the Offer Price over (ii) the per share exercise price of such Issuer option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each Issuer option that was outstanding (whether vested or unvested) immediately prior to the Effective Time and then exercisable for a per share exercise price less than the Offer Price that would be payable in respect of the Shares underlying such Issuer option (was cancelled and automatically converted into solely the right to receive, for each Share underlying such Issuer option, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the excess of (i) the Offer Price over (ii) the per share exercise price of such Issuer option."}],"balance_after":0,"derivative":{"exercise_price":14.35,"underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0000899243-20-031749","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1333482/000089924320031749/doc4.xml","form_type":"4"}},{"id":2972851,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-20T01:16:28.000Z","date":"2020-11-17","kind":"other","acquired":false,"shares":4100,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of October 3, 2020, by and among the Issuer, Bristol-Myers Squibb Company (\"Parent\"), and Gotham Merger Sub Inc., a direct wholly owned subsidiary of Parent (\"Merger Sub\"), pursuant to which Merger Sub completed a tender offer for shares of common stock of the Issuer (each, a \"Share\") and thereafter merged with and into the Issuer (the \"Merger\") effective as of November 17, 2020 (the \"Effective Time\"). At the Effective Time, each issued and outstanding Share was cancelled and converted into the right to receive $225.00 in cash (the \"Offer Price\") without interest and subject to applicable withholding taxes."},{"field":"shares","element":"transactionShares","label":"F2","text":"A portion of this amount consists of unvested restricted stock units (\"RSUs\"). Pursuant to the terms of the Merger Agreement, each Issuer RSU that was outstanding immediately prior to the Effective Time, whether vested or unvested, was cancelled at the Effective Time and automatically converted into the right to receive for each Share underlying such RSU, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the Offer Price."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of October 3, 2020, by and among the Issuer, Bristol-Myers Squibb Company (\"Parent\"), and Gotham Merger Sub Inc., a direct wholly owned subsidiary of Parent (\"Merger Sub\"), pursuant to which Merger Sub completed a tender offer for shares of common stock of the Issuer (each, a \"Share\") and thereafter merged with and into the Issuer (the \"Merger\") effective as of November 17, 2020 (the \"Effective Time\"). At the Effective Time, each issued and outstanding Share was cancelled and converted into the right to receive $225.00 in cash (the \"Offer Price\") without interest and subject to applicable withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"A portion of this amount consists of unvested restricted stock units (\"RSUs\"). Pursuant to the terms of the Merger Agreement, each Issuer RSU that was outstanding immediately prior to the Effective Time, whether vested or unvested, was cancelled at the Effective Time and automatically converted into the right to receive for each Share underlying such RSU, without interest and subject to deduction for any required withholding under applicable tax law, an amount in cash from Parent or the Issuer equal to the Offer Price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-20-031749","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1333482/000089924320031749/doc4.xml","form_type":"4"}},{"id":3092283,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option","published_at":"2020-07-02T20:11:23.000Z","date":"2020-06-30","kind":"grant","acquired":true,"shares":18760,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in twelve substantially equal monthly installments following the date of grant. The date of grant is June 30, 2020."}],"balance_after":18760,"derivative":{"exercise_price":25.48,"expiration_date":"2030-06-29","underlying":"Class A Common Shares","underlying_shares":18760},"source":{"system":"sec-edgar","filing":"0001104659-20-080548","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000110465920080548/a4.xml","form_type":"4"}},{"id":3101690,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-06-23T22:26:03.000Z","date":"2020-06-13","kind":"exercise","acquired":false,"shares":2300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"RSUs convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock.  The shares of Common Stock underlying the RSUs vest in a single installment on the first anniversary of the grant date, such that all of the underlying shares shall be vested on June 13, 2020, subject to the Reporting Person's continued service on the Issuer's Board of Directors.  The shares of Common Stock underlying the RSUs are subject to full acceleration of vesting with respect to all then-unvested shares upon the consummation of a Sale Event (as defined in the Issuer's 2015 Stock Option and Incentive Plan, as amended)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock.  The shares of Common Stock underlying the RSUs vest in a single installment on the first anniversary of the grant date, such that all of the underlying shares shall be vested on June 13, 2020, subject to the Reporting Person's continued service on the Issuer's Board of Directors.  The shares of Common Stock underlying the RSUs are subject to full acceleration of vesting with respect to all then-unvested shares upon the consummation of a Sale Event (as defined in the Issuer's 2015 Stock Option and Incentive Plan, as amended)."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2300},"source":{"system":"sec-edgar","filing":"0000899243-20-017510","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1333482/000089924320017510/doc4a.xml","form_type":"4/A","original_submission_date":"2020-06-16"}},{"id":3101689,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-23T22:26:03.000Z","date":"2020-06-13","kind":"exercise","acquired":true,"shares":2300,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"RSUs convert into common stock on a one-for-one basis."}],"balance_after":2300,"source":{"system":"sec-edgar","filing":"0000899243-20-017510","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1333482/000089924320017510/doc4a.xml","form_type":"4/A","original_submission_date":"2020-06-16"}},{"id":3102906,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-06-22T22:38:35.000Z","date":"2020-06-18","kind":"grant","acquired":true,"shares":1800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock. The shares of Common Stock underlying the RSUs vest in a single installment on the first anniversary of the grant date, subject to the Reporting Person's continued service on the Issuer's Board of Directors. The shares of Common Stock underlying the RSUs are subject to full acceleration of vesting with respect to all then-unvested shares upon the consummation of a Sale Event (as defined in the Issuer's 2015 Stock Option and Incentive Plan, as amended)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock. The shares of Common Stock underlying the RSUs vest in a single installment on the first anniversary of the grant date, subject to the Reporting Person's continued service on the Issuer's Board of Directors. The shares of Common Stock underlying the RSUs are subject to full acceleration of vesting with respect to all then-unvested shares upon the consummation of a Sale Event (as defined in the Issuer's 2015 Stock Option and Incentive Plan, as amended)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock. The shares of Common Stock underlying the RSUs vest in a single installment on the first anniversary of the grant date, subject to the Reporting Person's continued service on the Issuer's Board of Directors. The shares of Common Stock underlying the RSUs are subject to full acceleration of vesting with respect to all then-unvested shares upon the consummation of a Sale Event (as defined in the Issuer's 2015 Stock Option and Incentive Plan, as amended)."}],"balance_after":1800,"derivative":{"underlying":"Common Stock","underlying_shares":1800},"source":{"system":"sec-edgar","filing":"0000899243-20-017410","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1333482/000089924320017410/doc4.xml","form_type":"4"}},{"id":3102905,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-22T22:38:35.000Z","date":"2020-06-18","kind":"grant","acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable in 12 equal monthly installments after June 18, 2020, subject to the Reporting Person's continued service on the Issuer's Board of Directors. This option is subject to full acceleration of vesting with respect to all then-unvested shares upon the consummation of a Sale Event (as defined in the Issuer's 2015 Stock Option and Incentive Plan, as amended)."}],"balance_after":3000,"derivative":{"exercise_price":100.27,"expiration_date":"2030-06-17","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0000899243-20-017410","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1333482/000089924320017410/doc4.xml","form_type":"4"}},{"id":3106584,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-17T20:30:21.000Z","date":"2020-06-15","kind":"grant","acquired":true,"shares":4432,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option, granted pursuant to the Issuer's 2019 Omnibus Incentive Plan, vests as to one-twelfth of the shares on July 15, 2020 and each month thereafter, subject to the reporting person continuing as a service provider through each such date."}],"balance_after":4432,"derivative":{"exercise_price":88.42,"expiration_date":"2030-06-15","underlying":"Class A Common Stock","underlying_shares":4432},"source":{"system":"sec-edgar","filing":"0001209191-20-037272","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1333482/000120919120037272/doc4.xml","form_type":"4"}},{"id":3108597,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-06-16T22:07:20.000Z","date":"2020-06-13","kind":"exercise","acquired":true,"shares":2300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"RSUs convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock.  The shares of Common Stock underlying the RSUs vest in a single installment on the first anniversary of the grant date, such that all of the underlying shares shall be vested on June 13, 2020, subject to the Reporting Person's continued service on the Issuer's Board of Directors.  The shares of Common Stock underlying the RSUs are subject to full acceleration of vesting with respect to all then-unvested shares upon the consummation of a Sale Event (as defined in the Issuer's 2015 Stock Option and Incentive Plan, as amended)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock.  The shares of Common Stock underlying the RSUs vest in a single installment on the first anniversary of the grant date, such that all of the underlying shares shall be vested on June 13, 2020, subject to the Reporting Person's continued service on the Issuer's Board of Directors.  The shares of Common Stock underlying the RSUs are subject to full acceleration of vesting with respect to all then-unvested shares upon the consummation of a Sale Event (as defined in the Issuer's 2015 Stock Option and Incentive Plan, as amended)."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2300},"source":{"system":"sec-edgar","filing":"0000899243-20-016686","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1333482/000089924320016686/doc4.xml","form_type":"4"}},{"id":3108596,"issuer":{"id":145206,"kind":"organization","name":"MyoKardia, Inc.","symbol":"MYOK"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-16T22:07:20.000Z","date":"2020-06-13","kind":"exercise","acquired":true,"shares":2300,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"RSUs convert into common stock on a one-for-one basis."}],"balance_after":2300,"source":{"system":"sec-edgar","filing":"0000899243-20-016686","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1333482/000089924320016686/doc4.xml","form_type":"4"}},{"id":3192952,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-03-27T23:33:24.000Z","date":"2020-03-26","kind":"grant","acquired":true,"shares":10330,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option, granted pursuant to the Issuer's 2019 Omnibus Incentive Plan, vests as to one-third of the shares on March 26, 2021 and as to one thirty-sixth of the shares each month thereafter, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":10330,"derivative":{"exercise_price":61.04,"expiration_date":"2030-03-26","underlying":"Class A Common Stock","underlying_shares":10330},"source":{"system":"sec-edgar","filing":"0001209191-20-021545","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1333482/000120919120021545/doc4.xml","form_type":"4"}},{"id":3371583,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy) Holding","published_at":"2019-11-14T21:38:52.000Z","date":"2019-11-08","kind":"disposition_to_issuer","acquired":false,"shares":75610,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"Disposed of in connection with the Merger, whereby such Issuer stock option was assumed by Exact Sciences and converted into a corresponding award for an option to purchase 57,866 shares of Exact Sciences common stock with an exercise price of $94.76 per share."}],"balance_after":0,"derivative":{"exercise_price":72.52,"expiration_date":"2029-01-29","underlying":"Common Stock","underlying_shares":75610},"source":{"system":"sec-edgar","filing":"0001209191-19-056630","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119056630/doc4.xml","form_type":"4"}},{"id":3371582,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy) Holding","published_at":"2019-11-14T21:38:52.000Z","date":"2019-11-08","kind":"disposition_to_issuer","acquired":false,"shares":92869,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"Disposed of in connection with the Merger, whereby such Issuer stock option was assumed by Exact Sciences and converted into a corresponding award for an option to purchase 71,075 shares of Exact Sciences common stock with an exercise price of $43.40 per share."}],"balance_after":0,"derivative":{"exercise_price":33.21,"expiration_date":"2028-01-31","underlying":"Common Stock","underlying_shares":92869},"source":{"system":"sec-edgar","filing":"0001209191-19-056630","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119056630/doc4.xml","form_type":"4"}},{"id":3371581,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy) Holding","published_at":"2019-11-14T21:38:52.000Z","date":"2019-11-08","kind":"disposition_to_issuer","acquired":false,"shares":72231,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"Disposed of in connection with the Merger, whereby such Issuer stock option was cancelled in exchange for a cash payment of $999,359, less applicable tax withholdings, and 16,368 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019."}],"balance_after":92869,"derivative":{"exercise_price":33.21,"expiration_date":"2028-01-31","underlying":"Common Stock","underlying_shares":72231},"source":{"system":"sec-edgar","filing":"0001209191-19-056630","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119056630/doc4.xml","form_type":"4"}},{"id":3371580,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy) Holding","published_at":"2019-11-14T21:38:52.000Z","date":"2019-11-08","kind":"disposition_to_issuer","acquired":false,"shares":59844,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"Disposed of in connection with the Merger, whereby such Issuer stock option was assumed by Exact Sciences and converted into a corresponding award for an option to purchase 45,800 shares of Exact Sciences common stock with an exercise price of $35.91 per share."}],"balance_after":0,"derivative":{"exercise_price":27.48,"expiration_date":"2027-01-31","underlying":"Common Stock","underlying_shares":59844},"source":{"system":"sec-edgar","filing":"0001209191-19-056630","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119056630/doc4.xml","form_type":"4"}},{"id":3371579,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy) Holding","published_at":"2019-11-14T21:38:52.000Z","date":"2019-11-08","kind":"disposition_to_issuer","acquired":false,"shares":131656,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Disposed of in connection with the Merger, whereby such Issuer stock option was cancelled in exchange for a cash payment of $2,131,936, less applicable tax withholdings, and 34,919 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019."}],"balance_after":59844,"derivative":{"exercise_price":27.48,"expiration_date":"2027-01-31","underlying":"Common Stock","underlying_shares":131656},"source":{"system":"sec-edgar","filing":"0001209191-19-056630","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119056630/doc4.xml","form_type":"4"}},{"id":3371578,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy) Holding","published_at":"2019-11-14T21:38:52.000Z","date":"2019-11-08","kind":"disposition_to_issuer","acquired":false,"shares":12822,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Disposed of in connection with the Merger, whereby such Issuer stock option was assumed by Exact Sciences and converted into a corresponding award for an option to purchase 9,813 shares of Exact Sciences common stock with an exercise price of $35.28 per share."}],"balance_after":0,"derivative":{"exercise_price":27,"expiration_date":"2026-02-16","underlying":"Common Stock","underlying_shares":12822},"source":{"system":"sec-edgar","filing":"0001209191-19-056630","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119056630/doc4.xml","form_type":"4"}},{"id":3371577,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy) Holding","published_at":"2019-11-14T21:38:52.000Z","date":"2019-11-08","kind":"disposition_to_issuer","acquired":false,"shares":141038,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Disposed of in connection with the Merger, whereby such Issuer stock option was cancelled in exchange for a cash payment of $2,311,715, less applicable tax withholdings, and 37,864 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019."}],"balance_after":12822,"derivative":{"exercise_price":27,"expiration_date":"2026-02-16","underlying":"Common Stock","underlying_shares":141038},"source":{"system":"sec-edgar","filing":"0001209191-19-056630","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119056630/doc4.xml","form_type":"4"}},{"id":3371576,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-11-14T21:38:52.000Z","date":"2019-11-08","kind":"disposition_to_issuer","acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Disposed of in connection with the Merger, whereby such Issuer stock option was cancelled in exchange for a cash payment of $1,481,074, less applicable tax withholdings, and 24,258 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019."}],"balance_after":0,"derivative":{"exercise_price":30.84,"expiration_date":"2024-01-28","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-19-056630","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119056630/doc4.xml","form_type":"4"}},{"id":3371575,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-11-14T21:38:52.000Z","date":"2019-11-08","kind":"disposition_to_issuer","acquired":false,"shares":67500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Disposed of in connection with the Merger, whereby such Issuer stock option was cancelled in exchange for a cash payment of $1,077,212, less applicable tax withholdings, and 17,643 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019."}],"balance_after":0,"derivative":{"exercise_price":28.05,"expiration_date":"2023-01-31","underlying":"Common Stock","underlying_shares":67500},"source":{"system":"sec-edgar","filing":"0001209191-19-056630","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119056630/doc4.xml","form_type":"4"}},{"id":3371574,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-11-14T21:38:52.000Z","date":"2019-11-08","kind":"disposition_to_issuer","acquired":false,"shares":36168,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Disposed of in connection with the Merger, whereby such Issuer restricted stock unit (\"RSU\") was assumed by Exact Sciences and converted into a corresponding award for 27,680 RSUs of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-19-056630","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119056630/doc4.xml","form_type":"4"}},{"id":3371573,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-11-14T21:38:52.000Z","date":"2019-11-08","kind":"disposition_to_issuer","acquired":false,"shares":68268,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by the Popovits 2010 Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Disposed of in connection with the Merger, whereby such shares of Issuer common stock were cancelled and converted into the right to receive a cash payment of $1,877,453 and 30,749 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-19-056630","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119056630/doc4.xml","form_type":"4"}},{"id":3371572,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-11-14T21:38:52.000Z","date":"2019-11-08","kind":"disposition_to_issuer","acquired":false,"shares":12298,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by Morgan Stanley as Custodian for Benefit of Kimberly Popovits"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Disposed of in connection with the acquisition of Issuer (the \"Merger\") by Exact Sciences Corporation (\"Exact Sciences\") pursuant to the Agreement and Plan of Merger, dated July 28, 2019 (the \"Merger Agreement\"), among Exact Sciences,Spring Acquisition Corp., and Issuer, whereby such shares of Issuer common stock were cancelled and converted into the right to receive a cash payment of $338,229 and 5,539 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-19-056630","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119056630/doc4.xml","form_type":"4"}},{"id":3395496,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-10-09T17:11:24.000Z","date":"2019-10-08","kind":"sale","acquired":false,"shares":10000,"price":67.7364,"value":677364.0,"ownership":{"direct":false,"nature":"Held by the Popovits 2010 Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on December 10, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents weighted average sale price. Actual sale prices ranged from $67.37 to $68.26."}],"balance_after":68268,"source":{"system":"sec-edgar","filing":"0001209191-19-052835","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119052835/doc4.xml","form_type":"4"}},{"id":3417737,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-09-11T16:16:59.000Z","date":"2019-09-09","kind":"sale","acquired":false,"shares":600,"price":74.0992,"value":44459.52,"ownership":{"direct":false,"nature":"Held by the Popovits 2010 Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on December 10, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents weighted average sale price. Actual sale prices ranged from $73.73 to $74.46."}],"balance_after":78268,"source":{"system":"sec-edgar","filing":"0001209191-19-049154","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119049154/doc4.xml","form_type":"4"}},{"id":3417736,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-09-11T16:16:59.000Z","date":"2019-09-09","kind":"sale","acquired":false,"shares":2483,"price":73.3488,"value":182125.0704,"ownership":{"direct":false,"nature":"Held by the Popovits 2010 Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on December 10, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents weighted average sale price. Actual sale prices ranged from $72.69 to $73.68."}],"balance_after":78868,"source":{"system":"sec-edgar","filing":"0001209191-19-049154","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119049154/doc4.xml","form_type":"4"}},{"id":3417735,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-09-11T16:16:59.000Z","date":"2019-09-09","kind":"sale","acquired":false,"shares":6917,"price":72.0978,"value":498700.4826,"ownership":{"direct":false,"nature":"Held by the Popovits 2010 Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on December 10, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents weighted average sale price. Actual sale prices ranged from $71.69 to $72.67."}],"balance_after":81351,"source":{"system":"sec-edgar","filing":"0001209191-19-049154","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119049154/doc4.xml","form_type":"4"}},{"id":3417734,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-09-11T16:16:59.000Z","date":"2019-08-22","kind":"gift","acquired":false,"shares":10200,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by the Popovits 2010 Trust"},"balance_after":88268,"source":{"system":"sec-edgar","filing":"0001209191-19-049154","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119049154/doc4.xml","form_type":"4"}},{"id":3439016,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-08-14T16:21:10.000Z","date":"2019-08-13","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The option became exercisable as to 25% of the shares on February 3, 2013, and became exercisable as to 1/48th of the shares each full month thereafter."}],"balance_after":0,"derivative":{"exercise_price":29.34,"expiration_date":"2022-02-03","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-19-045899","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119045899/doc4.xml","form_type":"4"}},{"id":3439015,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-08-14T16:21:10.000Z","date":"2019-08-12","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The option became exercisable as to 25% of the shares on February 3, 2013, and became exercisable as to 1/48th of the shares each full month thereafter."}],"balance_after":15000,"derivative":{"exercise_price":29.34,"expiration_date":"2022-02-03","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-19-045899","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119045899/doc4.xml","form_type":"4"}},{"id":3439014,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-08-14T16:21:10.000Z","date":"2019-08-13","kind":"sale","acquired":false,"shares":5091,"price":74.6734,"value":380162.2794,"ownership":{"direct":false,"nature":"Held by the Popovits 2010 Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on December 10, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents weighted average sale price. Actual sale prices ranged from $74.11 to $75.10."}],"balance_after":98468,"source":{"system":"sec-edgar","filing":"0001209191-19-045899","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119045899/doc4.xml","form_type":"4"}},{"id":3439013,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-08-14T16:21:10.000Z","date":"2019-08-13","kind":"sale","acquired":false,"shares":4909,"price":73.7224,"value":361903.2616,"ownership":{"direct":false,"nature":"Held by the Popovits 2010 Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on December 10, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Represents weighted average sale price. Actual sale prices ranged from $73.08 to $74.02."}],"balance_after":103559,"source":{"system":"sec-edgar","filing":"0001209191-19-045899","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119045899/doc4.xml","form_type":"4"}},{"id":3439012,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-08-14T16:21:10.000Z","date":"2019-08-13","kind":"sale","acquired":false,"shares":7607,"price":74.6802,"value":568092.2814,"ownership":{"direct":false,"nature":"Held by the Popovits 2010 Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on December 10, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents weighted average sale price. Actual sale prices ranged from $74.11 to $75.10."}],"balance_after":108468,"source":{"system":"sec-edgar","filing":"0001209191-19-045899","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119045899/doc4.xml","form_type":"4"}},{"id":3439011,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-08-14T16:21:10.000Z","date":"2019-08-13","kind":"sale","acquired":false,"shares":7393,"price":73.724,"value":545041.532,"ownership":{"direct":false,"nature":"Held by the Popovits 2010 Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on December 10, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents weighted average sale price. Actual sale prices ranged from $73.08 to $74.05."}],"balance_after":116075,"source":{"system":"sec-edgar","filing":"0001209191-19-045899","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119045899/doc4.xml","form_type":"4"}},{"id":3439010,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-08-14T16:21:10.000Z","date":"2019-08-13","kind":"exercise","acquired":true,"shares":15000,"price":29.34,"value":440100.0,"ownership":{"direct":false,"nature":"Held by the Popovits 2010 Trust"},"balance_after":123468,"source":{"system":"sec-edgar","filing":"0001209191-19-045899","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119045899/doc4.xml","form_type":"4"}},{"id":3439009,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-08-14T16:21:10.000Z","date":"2019-08-12","kind":"sale","acquired":false,"shares":447,"price":73.7588,"value":32970.1836,"ownership":{"direct":false,"nature":"Held by the Popovits 2010 Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on December 10, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents weighted average sale price. Actual sale prices ranged from $73.74 to $73.78."}],"balance_after":108468,"source":{"system":"sec-edgar","filing":"0001209191-19-045899","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119045899/doc4.xml","form_type":"4"}},{"id":3439008,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-08-14T16:21:10.000Z","date":"2019-08-12","kind":"sale","acquired":false,"shares":24553,"price":73.2979,"value":1799683.3387,"ownership":{"direct":false,"nature":"Held by the Popovits 2010 Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on December 10, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents weighted average sale price. Actual sale prices ranged from $72.73 to $73.70."}],"balance_after":108915,"source":{"system":"sec-edgar","filing":"0001209191-19-045899","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119045899/doc4.xml","form_type":"4"}},{"id":3439007,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-08-14T16:21:10.000Z","date":"2019-08-12","kind":"exercise","acquired":true,"shares":25000,"price":29.34,"value":733500.0,"ownership":{"direct":false,"nature":"Held by the Popovits 2010 Trust"},"balance_after":133468,"source":{"system":"sec-edgar","filing":"0001209191-19-045899","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119045899/doc4.xml","form_type":"4"}},{"id":3441354,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-08-12T19:08:47.000Z","date":"2019-08-09","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option became exercisable as to 25% of the shares on February 5, 2013, and became exercisable as to 1/48th of the shares each full month thereafter."}],"balance_after":40000,"derivative":{"exercise_price":29.34,"expiration_date":"2022-02-05","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-19-045633","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119045633/doc4.xml","form_type":"4"}},{"id":3441353,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-08-12T19:08:47.000Z","date":"2019-08-08","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option became exercisable as to 25% of the shares on February 5, 2013, and became exercisable as to 1/48th of the shares each full month thereafter."}],"balance_after":65000,"derivative":{"exercise_price":29.34,"expiration_date":"2022-02-05","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-19-045633","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119045633/doc4.xml","form_type":"4"}},{"id":3441352,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-08-12T19:08:47.000Z","date":"2019-08-09","kind":"sale","acquired":false,"shares":1000,"price":74.3691,"value":74369.1,"ownership":{"direct":false,"nature":"Held by the Popovits 2010 Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on December 10, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents weighted average sale price. Actual sale prices ranged from $74.24 to $74.45."}],"balance_after":108468,"source":{"system":"sec-edgar","filing":"0001209191-19-045633","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119045633/doc4.xml","form_type":"4"}},{"id":3441351,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-08-12T19:08:47.000Z","date":"2019-08-09","kind":"sale","acquired":false,"shares":24000,"price":73.6322,"value":1767172.8,"ownership":{"direct":false,"nature":"Held by the Popovits 2010 Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on December 10, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents weighted average sale price. Actual sale prices ranged from $73.24 to $74.15."}],"balance_after":109468,"source":{"system":"sec-edgar","filing":"0001209191-19-045633","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119045633/doc4.xml","form_type":"4"}},{"id":3441350,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-08-12T19:08:47.000Z","date":"2019-08-09","kind":"exercise","acquired":true,"shares":25000,"price":29.34,"value":733500.0,"ownership":{"direct":false,"nature":"Held by the Popovits 2010 Trust"},"balance_after":133468,"source":{"system":"sec-edgar","filing":"0001209191-19-045633","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119045633/doc4.xml","form_type":"4"}},{"id":3441349,"issuer":{"id":153816,"kind":"organization","name":"GENOMIC HEALTH INC","symbol":"GHDX"},"owners":[{"id":36274,"kind":"person","name":"Popovits Kimberly J","position":1,"cik":"0001333482","reported_name":"Popovits Kimberly J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-08-12T19:08:47.000Z","date":"2019-08-08","kind":"sale","acquired":false,"shares":9235,"price":74.2252,"value":685469.722,"ownership":{"direct":false,"nature":"Held by the Popovits 2010 Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on December 10, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents weighted average sale price. Actual sale prices ranged from $74.03 to $74.39."}],"balance_after":108468,"source":{"system":"sec-edgar","filing":"0001209191-19-045633","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1131324/000120919119045633/doc4.xml","form_type":"4"}}],"next_cursor":"2019-08-12T19:08:47.000000Z,3441349"}